Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 347867, 10 pages
http://dx.doi.org/10.1155/2015/347867
Research Article

Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival

1Physiopathology of Human Reproduction, IRCCS A.O.U. San Martino-IST, 16132 Genoa, Italy
2Laboratory of Biotherapy, IRCCS A.O.U. San Martino-IST, 16132 Genoa, Italy
3Laboratory of Oncology, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy
4Oncology Unit, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy
5Epidemiology, Biostatistics and Committees Unit, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy
6Neuroblastoma Laboratory, Pediatric Research Institute, Fondazione Città della Speranza, 35127 Padua, Italy

Received 10 July 2014; Revised 12 January 2015; Accepted 14 January 2015

Academic Editor: Mohammad Owais

Copyright © 2015 Sara Stigliani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sara Stigliani, Michela Croce, Fabio Morandi, et al., “Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival,” BioMed Research International, vol. 2015, Article ID 347867, 10 pages, 2015. doi:10.1155/2015/347867